Portfolio companies.
34,000+ PE-backed.

Active investments and exits across European private equity portfolios.
Filter by sector, geography, status. Find the right deal comp in seconds.

Active deals

241

currently held

Exits tracked

163

hand-checked

Sectors covered

across the portfolio

Countries covered

from every market

Latest activityLast event 2026-10-07

BP Technology VenturesadminDirector Departure · Resignation of MORELAND, Jennifer Lynne (director) · director resigned · governance change5 days ago

BP Technology Ventures5 days ago

Director Departure · Resignation of MORELAND, Jennifer Lynne (director) · director resigned · governance change

admin

B.P. Marsh & PartnerscapitalCapital Event · capital-return-purchase-own-shares-treasury-capital-date · Capital structure change5 days ago

B.P. Marsh & Partners5 days ago

Capital Event · capital-return-purchase-own-shares-treasury-capital-date · Capital structure change

capital

Arkea CapitaladminBoard change · Management board member change:: TRIDEAU Thomas, Jérôme · Change in the management board6 days ago

Arkea Capital6 days ago

Board change · Management board member change:: TRIDEAU Thomas, Jérôme · Change in the management board

admin

Caledonia InvestmentscapitalCapital Event · capital-cancellation-shares · Capital structure change6 days ago

Caledonia Investments6 days ago

Capital Event · capital-cancellation-shares · Capital structure change

capital

Cervinvest CapitaladminCEO change · Appointment of CEO De Jongh, Guillaume · New CEO appointed1 week ago

Cervinvest Capital1 week ago

CEO change · Appointment of CEO De Jongh, Guillaume · New CEO appointed

admin

Cervinvest CapitaladminChairman change · Appointment of Chairman Radix, Maxence. Departure of CEO Rouland, Antoine · New Chairman appointed. CEO departure · leadership transition underway1 week ago

Cervinvest Capital1 week ago

Chairman change · Appointment of Chairman Radix, Maxence. Departure of CEO Rouland, Antoine · New Chairman appointed. CEO departure · leadership transition underway

admin

Company	Sector	Geo	Investor	Entry	Hold	Status	Buyer	MOIC
NUCLIDIUM AG Seedfonds Bayern	Pharma	Switzerland	Bayern Kapital	2025	1yr	Active	–	–
Oralance Pharma CapDecisif 3	Pharma	France	Karista	2008	18yr	Active	–	–
Orexo Novo Holdings Growth Investments	Pharma	Sweden	Novo Holdings	2010	16yr	Active	–	–
Orsini Pharmaceutical Services Carlyle Japan	Pharma	Japan	The Carlyle Group	–	–	Active	–	–
Pelago Bioscience Impilo Investment Pool 2	Pharma	Sweden	Impilo	2023	3yr	Active	–	–
Pentapharm Orlando Capital V	Pharma	Switzerland	Orlando Management	2025	1yr	Active	–	–
Pharmactive Siparex Midcap 4	Pharma	France	Siparex	2021	5yr	Active	–	–
PharMEDium Healthcare Corporation CD&R Other Investments	Pharma	USA	CD&R	–	–	Active	–	–
PharmEste Principia Fund	Pharma	Italy	Principia SGR	2007	19yr	Active	–	–
Pharmivoire Nouvelle IPAE 1	Pharma	Ivory Coast	Investisseurs et Partenaires	2014	12yr	Active	–	–
PHERECYDES PHARMA Loire Valley Invest	Pharma	France	Go Capital	2018	8yr	Active	–	–
Presidio Pharmaceuticals Sobera Capital Fund IV	Pharma	United States	Sobera Capital	2018	8yr	Active	–	–
Prolevi Bio Almi Invest (Regional funds)	Pharma	Sweden	Almi Invest	2022	4yr	Active	–	–
Purpose Pharma Eir Ventures I	Pharma	Sweden	Eir Ventures	2024	2yr	Active	–	–
Queisser Pharma HGDF Evergreen Holding	Pharma	Germany	HGDF Familienholding	1976	50yr	Active	–	–
Ritedose Novo Holdings Principal Investments	Pharma	United States	Novo Holdings	2022	4yr	Active	–	–
Rosemont Pharmaceuticals Inflexion Continuation Fund I	Pharma	UK	Inflexion	2025	1yr	Active	–	–
Rubicon Research General Atlantic Partners (Bermuda) IV, L.P.	Pharma	United States	General Atlantic	–	–	Active	–	–
Sanfer General Atlantic flagship growth equity fund	Pharma	Mexico	General Atlantic	–	–	Active	–	–
Scantox Impilo Investment Pool 2	Pharma	Denmark	Impilo	2021	5yr	Active	–	–
Searchlight Pharma Inc. Crédit Mutuel Equity	Pharma	Canada	Crédit Mutuel Equity	2017	9yr	Active	–	–
Shenzhen Salubris Pharmaceutical Co., Ltd Carlyle Sub-Saharan Africa Fund	Pharma	China	The Carlyle Group	–	–	Exited	–	–
Sobrera Pharma GU Ventures Evergreen	Pharma	Sweden	GU Ventures	2019	7yr	Active	–	–
Sterling Pharma Solutions GHO Capital Fund II LP	Pharma	UK	GHO Capital	2019	7yr	Active	–	–
Strike Pharma AB SLU Holding	Pharma	Sweden	SLU Holding	2021	5yr	Active	–	–
Veltio Pharma Almi Invest (Regional funds)	Pharma	Sweden	Almi Invest	2022	4yr	Active	–	–
Vicore Pharma HealthCap VII	Pharma	Sweden	HealthCap	2018	8yr	Active	–	–
Vivunt Pharma ADE Capital Sodical	Pharma	Spain	Sodical	2022	4yr	Active	–	–
Xellia Pharmaceuticals Novo Holdings Principal Investments	Pharma	Denmark	Novo Holdings	2013	13yr	Active	–	–
Xspray Pharma Flerie Invest	Pharma	Sweden	Flerie	2021	5yr	Active	–	–

Portfolio companies.34,000+ PE-backed.

Portfolio companies.
34,000+ PE-backed.